SCHEMBL30338255

SCHEMBL30338255

N#Cc1ccccc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL100731 1.00
Methane SCHEMBL27908574 0.97 TSHR (0.48)
SCHEMBL8576872 0.82 CYP1A2 (0.44)
SCHEMBL1966377 0.79 TSHR (0.41)
SCHEMBL8488017 0.79 CYP1A2 (0.42)
SCHEMBL2818597 0.78 TSHR (0.63)
SCHEMBL57480 0.78 TSHR (0.63)
SCHEMBL29352197 0.78 TSHR (0.63)
Water SCHEMBL19410621 0.78 TSHR (0.63)
Water SCHEMBL27896186 0.78 TSHR (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4648763-A2 COMPOUNDS FOR FGFRS INHIBITORS Cogent Biosciences, Inc. (US) 2025-11-19 EP disclosed
CN-119053551-A Nano iron phosphide particles, composite containing nano iron phosphide particles and reduction catalyst 国立大学法人大阪大学 2024-11-29 CN disclosed
WO-2024151638-A2 COMPOUNDS FOR FGFRS INHIBITORS COGENT BIOSCIENCES, INC. (US) 2024-07-18 WO disclosed
CN-115835866-A Cereblon binding compounds, compositions thereof, and methods of use thereof for treatment 新基公司 2023-03-21 CN disclosed